tiprankstipranks
iX Biopharma Ltd. (SG:42C)
SGX:42C
Singapore Market

iX Biopharma Ltd. (42C) Financial Statements

Compare
6 Followers

iX Biopharma Ltd. Financial Overview

iX Biopharma Ltd.'s market cap is currently S$18.51M. The company's EPS TTM is S$-0.014; its P/E ratio is ―; iX Biopharma Ltd. is scheduled to report earnings on February 7, 2025, and the estimated EPS forecast is S$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 21Jun 20Jun 19Jun 18Jun 17
Income Statement
Total Revenue
Gross Profit$ -382.00K$ -587.00K$ -529.00K$ -247.00K$ 2.24M
Operating Income$ -10.08M$ -11.04M$ -11.91M$ -14.45M$ -8.57M
EBITDA$ -7.00M$ -9.21M$ -11.82M$ -13.58M$ -6.06M
Net Income$ -8.23M$ -10.50M$ -2.99M$ -15.09M$ -7.39M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 18.86M$ 16.98M$ 26.69M$ 33.07M$ 44.25M
Total Debt$ 4.24M$ 3.92M$ 3.83M$ 4.54M$ 4.75M
Net Debt$ -1.97M$ -1.75M$ -12.04M$ -16.53M$ -26.34M
Total Liabilities$ 7.15M$ 6.81M$ 6.19M$ 11.55M$ 8.63M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -8.90M$ -9.31M$ -15.59M$ -9.55M$ -5.28M
Operating Cash Flow$ -8.35M$ -8.32M$ -13.90M$ -8.36M$ -4.16M
Investing Cash Flow
Financing Cash Flow
Currency in USD

iX Biopharma Ltd. Earnings and Revenue History

iX Biopharma Ltd. Debt to Assets

iX Biopharma Ltd. Cash Flow

iX Biopharma Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis